New drug for Duchenne muscular dystrophy to be made available in Scotland January 13, 2025 By Amber Sunner
Duchenne muscular dystrophy treatment givinostat conditionally approved in the UK December 20, 2024 By Charlotte Roy
Disappointing results from phase 2 clinical trial for Duchenne muscular dystrophy December 19, 2024 By Charlotte Roy
NICE recommends new drug for Duchenne muscular dystrophy to be made available in England December 10, 2024 By Amber Sunner
Early Access Programme for new Duchenne muscular dystrophy treatment givinostat November 15, 2024 By Ellen Moye
Project secures funding to continue genotype phenotype correlation of the DMD and BMD brain September 18, 2024 By Amber Sunner
Celebrating 20 years: NorthStar a ‘shining light’ for people living with Duchenne muscular dystrophy September 7, 2024 By Ellen Moye
NICE publishes draft guidance on vamorolone for treating Duchenne muscular dystrophy March 27, 2024 By itineris
NICE starts appraisal process for Duchenne muscular dystrophy treatment vamorolone August 18, 2023 By itineris
Approval of gene therapy SRP-9001 in the USA ‒ a significant milestone in the treatment of Duchenne muscular dystrophy June 23, 2023 By itineris